Welcome to our dedicated page for Gpo Plus news (Ticker: GPOX), a resource for investors and traders seeking the latest updates and insights on Gpo Plus stock.
GPO Plus Inc (GPOX) operates at the nexus of group purchasing and technology-driven distribution, serving healthcare, CBD, and convenience retail sectors through its AI-optimized Direct Store Delivery network. This page aggregates official announcements and developments related to:
Strategic partnerships with product vendors and technology providers
Operational expansions of Regional and Mini Hub networks
PRISM+ platform enhancements for inventory management and route optimization
Product portfolio updates across healthcare and CBD verticals
Investors and industry professionals will find timely updates on GPOX's unique combination of group purchasing power and logistics technology. All content is sourced directly from company filings and authorized communications to ensure accuracy.
Bookmark this page for consolidated access to GPOX's evolving market strategy, technology implementations, and sector-specific growth initiatives. Check regularly for updates on their AI-driven distribution model serving 20,000+ retail locations nationwide.
GPO Plus, Inc. (GPOX) has engaged Lookhu to enhance its revenue and brand awareness through strategic content and influencer marketing initiatives. The partnership aims to leverage Lookhu's established connections with top influencers and celebrities, including Ray J and Snoop Dogg, to promote GPOX’s newly acquired brands, Nutriumph and Herberall. The campaign includes the development of advertising channels, content creation, syndication across social media platforms, and business development efforts to foster partnerships. A promotional offer of 30% off is currently available for shareholders.
GPOX has signed an asset purchase agreement to acquire Nutriumph® Supplements and its flagship product HERBERALL®, marking its entry into the lucrative Direct-To-Consumer Vitamin and Supplement sector. This acquisition is expected to further GPOX's growth strategy and expand its product offerings. Nadege Bellissan, founder of Nutriumph®, has been appointed CEO of the new division. Nutriumph® boasts a robust online sales presence across platforms like Amazon, Walmart Marketplace, and more, which will enhance GPOX's distribution capabilities.
GPOX has entered a strategic multi-year partnership with DEV Distribution as its Master Distributor, effective June 8, 2022. This agreement enables GPOX to distribute DEV's products, including vegan CBD-infused gummies, at Most Favored Nations pricing.
With DEV moving to a new facility capable of producing 30 million gummies monthly, this collaboration is expected to significantly enhance GPOX's growth in the vitamin and CBD sectors.
GPOX, under its growth strategy, has executed a letter of intent to acquire Nutriumph® Supplements and its leading product HERBERALL®. This acquisition, valued at 150,000 shares of restricted common stock and $50,000 cash, is anticipated to close by June 30, 2022. Nutriumph® specializes in natural, certified supplements designed for health and wellness. The partnership aims to enhance GPOX's portfolio and expand its market presence in the vitamin and supplement sector. GPOX plans to launch Nutriumph® products through its DISTRO+ distribution division.
GPO Plus (OTCQB: GPOX) has launched DISTRO+, a new Group Purchasing Organization (GPO) aimed at specialty retailers and wholesalers. The Phase One launch focuses on three key objectives: forming distribution agreements with brands, enrolling retailers as members, and identifying potential distributors for acquisition. DISTRO+ plans to offer competitive pricing and low minimum order quantities to its members while developing a diverse portfolio, particularly emphasizing hemp-derived products. This strategic initiative aims to consolidate and enhance purchasing power for independent distributors and retailers.
GPOX reported a quarterly revenue of $397,094, bringing year-to-date earnings to $995,813, reflecting a significant 160% growth compared to the 2021 Q3 year-to-date revenue of $622,384. The report was filed with the SEC for the fiscal third quarter ending January 31, 2022. CEO Brett Pojunis highlighted the company's momentum, underscoring a solid foundation with growing revenues and new product developments.
GPOX has announced the appointment of Bryan Garabrandt as Vice President of Sales and Marketing and Chief Technologist. With 15 years of experience in marketing and technology, Garabrandt's role focuses on enhancing the company's online presence and operational efficiency through data-driven strategies. GPOX aims to leverage his expertise to scale operations and continue revenue growth. CEO Brett H. Pojunis expressed enthusiasm over Garabrandt's leadership in navigating GPOX’s technology challenges.
GPOX plans to expand its offerings, pursue new industry-specific GPOs, and enhance team growth.
GPOX engages King Tide Media for investor relations support
GPO Plus, Inc. (OTCQB: GPOX) has appointed King Tide Media, LLC to enhance its investor and public relations efforts. The collaboration aims to boost awareness of GPOX within the investment community. CEO Brett H. Pojunis emphasized the importance of building a strong business foundation and inviting investors to participate in GPOX's growth. The company intends to strengthen its Shareholder Success Team, ensuring stakeholders stay informed about significant developments and news.
Wayne Smeal has joined GPOX as Chief Operating Officer and board member, bringing over 30 years of leadership experience from Fortune 500 companies and successful ventures in diverse industries. He previously founded Executive Tan, growing it to over 200 locations and achieving $20 million in annual revenue. Smeal aims to enhance GPOX's sales and product development, focusing on customer service and core business growth. The company plans to launch new Group Purchasing Organizations (GPOs) and product lines to further its market reach.
GPOX has launched AntigenTests.com, a project under HealthGPO, to provide competitive pricing and a reliable supply chain for FDA EUA approved Rapid Point-of-Care COVID-19 tests. This initiative aims to resolve issues of unreliable supply chains and inconsistent pricing that have plagued the market. The company highlights that the demand for COVID tests is expected to grow, particularly with new variants. Shareholders can expect potential revenue and membership growth as HealthGPO addresses these challenges effectively.
